Travere Therapeutics reports inducement grants under Nasdaq listing rule 5635(C)(4)
TVTX•Travere Therapeutics reported inducement grants under Nasdaq listing rule 5635(C)(4).
1. Inducement grants
Travere Therapeutics reported inducement grants under Nasdaq listing rule 5635(C)(4).
